PMC:7643666 / 3489-4442 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7643666","sourcedb":"PMC","sourceid":"7643666","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7643666","text":"Mammalian biodiversity is recognized as a risk factor for zoonotic disease emergence [13, 14, 15]. COVID-19, as a zoonotic disease, represents a high treat for regions with high biodiversity; it represents a high treat for regions like Italy, which is among the European countries richest in biodiversity [16, 17] (https://www.isprambiente.gov.it/en/archive/news-and-other-events/ispra-news/year-2015/may/biodiversity-in-italy). Strategies to contain infection are being adopted following the WHO recommendation [18] (https://www.who.int/publications/i/item/clinical-management-of-covid-19). However, given the high biodiversity, great attention is on identifying mammalian species occupying the Italian territory, which may act as potential new primary or secondary reservoir of SARS-CoV-2. Lastly, ecologically speaking, the control of a new virus generation may prevent endangered species extinction and avoid a severe threat to Italy's biodiversity.","tracks":[]}